Standex International Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
Standex International Quarterly Cash Flow Statements Table
Quarterly
|
Annual
Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-03-31 | 2013-12-31 | 2013-09-30 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities | |||||||||||||||||||||||
net income | 15,486,000 | 22,726,000 | 1,275,000 | 18,197,000 | 19,591,000 | 15,798,000 | 18,871,000 | 18,814,000 | 80,510,000 | 20,043,000 | 18,270,000 | 17,322,000 | 14,984,000 | 15,818,000 | 1,430,000 | 11,374,000 | 9,720,000 | -6,323,000 | 12,237,000 | 12,439,000 | 35,922,000 | 10,517,000 | 9,082,000 |
income from discontinued operations | 14,000 | -52,000 | -13,000 | 9,000 | -97,000 | -141,000 | -201,000 | -78,000 | -57,000 | -41,000 | -46,000 | -86,000 | -46,000 | -3,000 | -330,000 | -631,000 | -627,000 | -16,380,000 | -171,000 | -11,000 | |||
income from continuing operations | 15,472,000 | 22,778,000 | 1,288,000 | 18,188,000 | 19,688,000 | 15,939,000 | 19,072,000 | 18,892,000 | 80,567,000 | 20,084,000 | 18,316,000 | 17,408,000 | 15,030,000 | 15,821,000 | 1,760,000 | 12,005,000 | 10,347,000 | 10,057,000 | 12,408,000 | 12,450,000 | 13,315,000 | 10,643,000 | 10,113,000 |
adjustments to reconcile net income to net cash from operating activities: | |||||||||||||||||||||||
depreciation and amortization | 10,128,000 | 9,744,000 | 8,505,000 | 7,061,000 | 6,994,000 | 7,177,000 | 6,887,000 | 7,082,000 | 7,309,000 | 6,958,000 | 7,008,000 | 7,189,000 | 7,497,000 | 7,725,000 | 8,322,000 | 8,328,000 | 8,193,000 | 7,432,000 | 8,489,000 | 8,380,000 | 15,244,000 | 3,780,000 | 3,770,000 |
stock-based compensation | 813,000 | 2,723,000 | 2,587,000 | 2,568,000 | 1,287,000 | 3,700,000 | 2,631,000 | 2,193,000 | 3,809,000 | 2,135,000 | 2,564,000 | 3,588,000 | 2,536,000 | 2,089,000 | 1,370,000 | 2,533,000 | 1,755,000 | 465,000 | 2,063,000 | 2,757,000 | 361,000 | 1,470,000 | 849,000 |
gain on sale of real estate and equipment | |||||||||||||||||||||||
non-cash portion of restructuring charge | 411,000 | 495,000 | -753,000 | -143,000 | -744,000 | 549,000 | -51,000 | 397,000 | 1,312,000 | -117,000 | -1,066,000 | 258,000 | 386,000 | -49,000 | -46,000 | -78,000 | -414,000 | 62,000 | -27,000 | -122,000 | -3,423,000 | 48,000 | 3,294,000 |
(gain) loss on sale of business | |||||||||||||||||||||||
deferred income taxes | |||||||||||||||||||||||
life insurance benefit | 0 | 0 | -1,302,000 | ||||||||||||||||||||
contributions to defined benefit plans | -1,643,000 | -1,387,000 | -1,387,000 | -3,379,000 | -1,732,000 | -6,965,000 | -1,492,000 | -49,000 | -50,000 | -49,000 | -52,000 | -53,000 | -52,000 | -52,000 | -3,082,000 | -4,828,000 | -52,000 | -1,522,000 | -1,691,000 | -241,000 | -18,000 | -375,000 | -358,000 |
increase/(decrease) in cash from changes in assets and liabilities, net of effects from discontinued operations and business acquisitions: | |||||||||||||||||||||||
accounts receivables | |||||||||||||||||||||||
inventories | |||||||||||||||||||||||
prepaid expenses and other assets | |||||||||||||||||||||||
accounts payable | |||||||||||||||||||||||
accrued liabilities, pension and other liabilities | |||||||||||||||||||||||
income taxes payable | |||||||||||||||||||||||
net cash from operating activities from continuing operations | |||||||||||||||||||||||
net cash from operating activities from discontinued operations | |||||||||||||||||||||||
net cash from operating activities | 33,424,000 | 9,540,000 | 9,058,000 | 17,573,000 | 28,544,000 | 24,367,000 | 23,565,000 | 16,180,000 | 23,278,000 | 29,743,000 | -2,703,000 | 11,918,000 | 23,264,000 | 13,071,000 | 17,801,000 | 22,338,000 | 11,424,000 | 4,271,000 | 13,246,000 | 8,414,000 | 8,175,000 | 16,459,000 | 943,000 |
capex | 0 | -6,072,000 | -6,965,000 | -6,725,000 | 0 | -5,178,000 | -4,249,000 | -4,338,000 | -5,620,000 | -5,761,000 | -5,267,000 | -3,417,000 | -4,699,000 | -5,022,000 | -5,467,000 | -5,325,000 | -4,820,000 | -5,135,000 | -3,637,000 | -7,034,000 | -9,881,000 | -3,713,000 | -4,250,000 |
free cash flows | 33,424,000 | 3,468,000 | 2,093,000 | 10,848,000 | 28,544,000 | 19,189,000 | 19,316,000 | 11,842,000 | 17,658,000 | 23,982,000 | -7,970,000 | 8,501,000 | 18,565,000 | 8,049,000 | 12,334,000 | 17,013,000 | 6,604,000 | -864,000 | 9,609,000 | 1,380,000 | -1,706,000 | 12,746,000 | -3,307,000 |
cash flows from investing activities | |||||||||||||||||||||||
expenditures for property, plant and equipment | |||||||||||||||||||||||
expenditures for acquisitions, net of cash acquired | -1,509,000 | -57,729,000 | -1,139,000 | -18,467,000 | 0 | -29,229,000 | -8,000 | 0 | -27,398,000 | ||||||||||||||
expenditures for executive life insurance policies | |||||||||||||||||||||||
proceeds from sale of business | 0 | 7,500,000 | 0 | 274,000 | |||||||||||||||||||
proceeds from sale of real estate and equipment | |||||||||||||||||||||||
proceeds withdrawn from life insurance policies | |||||||||||||||||||||||
other investing activity | -104,000 | 3,493,000 | 411,000 | -1,419,000 | 55,000 | 43,000 | 4,072,000 | 1,677,000 | -31,000 | -1,724,000 | 76,000 | 199,000 | -483,000 | 1,622,000 | 376,000 | 3,105,000 | -3,492,000 | 10,000 | |||||
net cash from investing activities from continuing operations | |||||||||||||||||||||||
net cash from investing activities from discontinued operations | |||||||||||||||||||||||
net cash (used for) investing activities | |||||||||||||||||||||||
cash flows from financing activities | |||||||||||||||||||||||
proceeds from borrowings | 0 | 68,000,000 | 196,000,000 | 4,500,000 | 24,000,000 | ||||||||||||||||||
payments of debt | -27,000,000 | -22,999,000 | 0 | 0 | 0 | -25,000,000 | -210,200,000 | ||||||||||||||||
contingent consideration payment | 0 | 0 | -1,167,000 | 0 | 0 | -1,167,000 | 0 | ||||||||||||||||
activity under share-based payment plans | 207,000 | 227,000 | 155,000 | 1,637,000 | 200,000 | 136,000 | 421,000 | 768,000 | 176,000 | 159,000 | 835,000 | 171,000 | 171,000 | 976,000 | 146,000 | 278,000 | 693,000 | 450,000 | 178,000 | 949,000 | 814,000 | 66,000 | 72,000 |
purchase of treasury stock and other | |||||||||||||||||||||||
cash dividends paid | -3,836,000 | -3,835,000 | -3,834,000 | -3,528,000 | -3,527,000 | -3,535,000 | -3,552,000 | -3,288,000 | -3,300,000 | -3,325,000 | -3,074,000 | -3,129,000 | -3,129,000 | -2,890,000 | -2,923,000 | -2,932,000 | -2,692,000 | -2,725,000 | -2,723,000 | -2,463,000 | -5,064,000 | -1,263,000 | -1,004,000 |
net cash from financing activities | -30,952,000 | 41,392,000 | 376,324,000 | -6,273,000 | -8,530,000 | -7,623,000 | -49,678,000 | -22,389,000 | -19,790,000 | 12,201,000 | -14,832,000 | -3,004,000 | -12,581,000 | -11,389,000 | -5,138,000 | -7,108,000 | 14,663,000 | -5,592,000 | -11,085,000 | 82,284,000 | -7,305,000 | -2,507,000 | |
effect of exchange rate changes on cash | |||||||||||||||||||||||
net change in cash and cash equivalents | -5,268,000 | -11,337,000 | -43,437,000 | 10,381,000 | 15,404,000 | -3,625,000 | 15,594,000 | -68,876,000 | 61,790,000 | 10,066,000 | -1,416,000 | -13,253,000 | 16,472,000 | -5,684,000 | 8,930,000 | 15,412,000 | -25,111,000 | 10,378,000 | 8,675,000 | -2,901,000 | -10,557,000 | 2,005,000 | -5,009,000 |
cash and cash equivalents at beginning of year | 0 | 0 | 0 | 154,203,000 | 0 | 0 | 0 | 195,706,000 | 0 | 0 | 104,844,000 | 0 | 0 | 136,367,000 | 0 | 0 | 118,809,000 | 0 | 0 | 93,145,000 | 58,538,000 | 0 | 51,064,000 |
cash and cash equivalents at end of year | |||||||||||||||||||||||
supplemental disclosure of cash flow information: | |||||||||||||||||||||||
cash paid during the year for: | |||||||||||||||||||||||
interest | 7,918,000 | 9,684,000 | 2,660,000 | 895,000 | 1,009,000 | 858,000 | 942,000 | 1,280,000 | 961,000 | 1,127,000 | 1,098,000 | 1,230,000 | 1,292,000 | 1,269,000 | 1,227,000 | 1,302,000 | 1,225,000 | 1,613,000 | 1,574,000 | 1,841,000 | |||
income taxes, net of refunds | 10,808,000 | 10,679,000 | 766,000 | 5,479,000 | 8,226,000 | 5,730,000 | 8,891,000 | 5,119,000 | 9,242,000 | 3,402,000 | 9,420,000 | 6,853,000 | 1,322,000 | 6,622,000 | -2,897,000 | 2,610,000 | 5,753,000 | 6,605,000 | 4,475,000 | 5,114,000 | |||
changes in operating assets and liabilities | -24,802,000 | -1,125,000 | -6,748,000 | 4,042,000 | -3,287,000 | -11,834,000 | -7,578,000 | 785,000 | -29,475,000 | -16,461,000 | -1,784,000 | -12,448,000 | |||||||||||
net cash from operating activities - continuing operations | 9,551,000 | 9,115,000 | 17,547,000 | 24,442,000 | 23,760,000 | 16,407,000 | 23,264,000 | 29,796,000 | -2,705,000 | 11,929,000 | 23,613,000 | 13,086,000 | 17,830,000 | 22,274,000 | 9,234,000 | 7,668,000 | 13,507,000 | 8,315,000 | 4,779,000 | 18,929,000 | 1,252,000 | ||
net cash from operating activities - discontinued operations | -11,000 | -57,000 | 26,000 | -75,000 | -195,000 | -227,000 | 14,000 | -53,000 | 2,000 | -11,000 | -349,000 | -15,000 | -29,000 | 64,000 | 2,190,000 | -3,397,000 | |||||||
expenditures for property, plant, and equipment | -6,072,000 | -6,965,000 | -6,725,000 | -5,178,000 | -4,249,000 | -4,338,000 | -5,620,000 | -5,761,000 | -5,267,000 | -3,417,000 | -4,699,000 | -5,022,000 | -5,467,000 | -5,325,000 | -4,820,000 | -5,135,000 | -3,637,000 | -7,034,000 | -9,881,000 | -3,713,000 | -4,250,000 | ||
net cash from investing activities | -63,905,000 | -423,124,000 | -6,314,000 | -16,415,000 | -4,249,000 | -33,293,000 | 59,984,000 | -5,706,000 | -5,224,000 | -9,247,000 | -3,022,000 | -5,053,000 | 4,479,000 | -5,249,000 | -32,019,000 | 2,342,000 | |||||||
purchases of treasury stock and other | 0 | ||||||||||||||||||||||
effect of exchange rate changes on cash and cash equivalents | 1,636,000 | -5,695,000 | 5,395,000 | -3,047,000 | 3,901,000 | -2,085,000 | 917,000 | 5,819,000 | -5,690,000 | -1,092,000 | -766,000 | -1,121,000 | -1,961,000 | 3,461,000 | 2,592,000 | -2,352,000 | 2,036,000 | -2,572,000 | -3,295,000 | 56,000 | 795,000 | ||
cash and cash equivalents at end of period | -11,337,000 | -43,437,000 | 164,584,000 | -3,625,000 | 15,594,000 | 126,830,000 | 61,790,000 | 10,066,000 | 103,428,000 | -13,253,000 | 16,472,000 | 130,683,000 | 8,930,000 | 15,412,000 | 93,698,000 | 10,378,000 | 8,675,000 | 90,244,000 | 47,981,000 | 2,005,000 | 46,055,000 | ||
stock issued for business acquisition | 0 | ||||||||||||||||||||||
purchases of treasury stock | -4,382,000 | -5,131,000 | -4,492,000 | -22,158,000 | -5,065,000 | -5,124,000 | -8,393,000 | -11,874,000 | -46,000 | -9,500,000 | -8,612,000 | -2,484,000 | -5,109,000 | -8,062,000 | -175,000 | -771,000 | -14,133,000 | -2,061,000 | -3,045,000 | ||||
purchase of treasury stock | |||||||||||||||||||||||
net cash (used for) financing activities | |||||||||||||||||||||||
gain on sale of business | 0 | 0 | -274,000 | ||||||||||||||||||||
loss on sale of business | |||||||||||||||||||||||
net changes in operating assets and liabilities | -5,118,000 | 4,314,000 | -10,595,000 | -8,826,000 | -7,735,000 | -13,607,000 | -19,775,000 | 2,438,000 | -16,416,000 | ||||||||||||||
net cash from investing activities - continuing operations | 4,479,000 | ||||||||||||||||||||||
net cash from investing activities - discontinued operations | |||||||||||||||||||||||
borrowings on revolving credit facility | 0 | 500,000 | 16,500,000 | 71,800,000 | 9,000,000 | 25,700,000 | 172,150,000 | 16,800,000 | 17,700,000 | ||||||||||||||
payments of revolving credit facility | 0 | -500,000 | -16,500,000 | -46,800,000 | -11,000,000 | -34,500,000 | -69,150,000 | -20,800,000 | -17,700,000 | ||||||||||||||
net cash from investing activities- continuing operations | -32,019,000 | 2,342,000 | |||||||||||||||||||||
net cash from investing activities- discontinued operations | |||||||||||||||||||||||
net cash (used in) investing activities | -15,618,000 | -7,205,000 | -4,240,000 | ||||||||||||||||||||
proceeds from insurance recovery | 1,000,000 | 9,000,000 | |||||||||||||||||||||
net cash (used in) operating activities - discontinued operations | 99,000 | 3,396,000 | -2,470,000 | -309,000 | |||||||||||||||||||
deferred repatriation tax | |||||||||||||||||||||||
disposal of real estate and equipment | |||||||||||||||||||||||
proceeds from life insurance policies | |||||||||||||||||||||||
proceeds from sales of real estate and equipment | |||||||||||||||||||||||
see notes to unaudited condensed consolidated financial statements | |||||||||||||||||||||||
(income) income from discontinued operations | 126,000 | 1,031,000 | |||||||||||||||||||||
excess tax benefit from share-based payment activity | -47,000 | 1,470,000 |
We provide you with 20 years of cash flow statements for Standex International stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Standex International stock. Explore the full financial landscape of Standex International stock with our expertly curated income statements.
The information provided in this report about Standex International stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.